Cargando…

Specific ophtalmologic changes in late onset familial amyloid polyneuropathy (FAP) portuguese patients

Detalles Bibliográficos
Autores principales:	Ferreira, Natalia, Dias, David, Coelho, Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642078/ http://dx.doi.org/10.1186/1750-1172-10-S1-P63

Ejemplares similares

Ophtalmologic changes in transthyretin familial amyloid polyneuropathy (ATTR-FAP)
por: Ferreira, Natália
Publicado: (2015)

Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease
por: Raya-Cruz, Manuel, et al.
Publicado: (2015)

The hidden story behind gender differences in familial amyloid polyneuropathy (FAP) ATTRV30M
por: Santos, Diana, et al.
Publicado: (2015)

Unravelling the epidemiology of late-onset and asymptomatic carriers of FAP ATTR V30M in a Portuguese population
por: Lemos, Carolina, et al.
Publicado: (2015)

Specific ocular changes in TTR Met30-FAP after liver transplantation
por: Ferreira, Natalia, et al.
Publicado: (2015)

Epidemiology of transthyretin familial amyloid polyneuropathy in Portugal
por: Inês, Mónica, et al.
Publicado: (2015)

Effects of anti-TNF therapy on ophtalmological complications in children with rheumatic diseases
por: Frkovic, Marijan, et al.
Publicado: (2014)

Transthyretin-related Familial Amyloid Polyneuropathy (TTR-FAP) caused by a very rare, de novo mutation in a Polish patient.
por: Lipowska, Marta, et al.
Publicado: (2015)

Patient-reported outcomes on familial amyloid polyneuropathy (FAP)
por: Bolte, Fabian J., et al.
Publicado: (2020)

Diflunisal compassive use in transthyretin familial amyloidotic polyneuropathy (TTR-FAP): report of the first Spanish experience
por: Contesse, Sebastián E Azorín, et al.
Publicado: (2015)

Vitreous Amyloidosis as the Presenting Symptom of Familial Amyloid Polyneuropathy TTR Val30Met in a Portuguese Patient
por: Seca, Mariana, et al.
Publicado: (2014)

Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy
por: Lopes, Alice, et al.
Publicado: (2017)

The rehabilitation in the management of Transthyretin Familial Amyloid Polyneuropathy
por: Morier, Agnès, et al.
Publicado: (2015)

Transthyretin familial amyloid polyneuropathy (TTR‐FAP): Parameters for early diagnosis
por: Escolano‐Lozano, Fabiola, et al.
Publicado: (2017)

Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan
por: Miyake, Zenshi, et al.
Publicado: (2018)

Psychopathological dimensions in familial amyloid polyneuropathy patients
por: Lopes, Alice, et al.
Publicado: (2015)

Transthyretin familial amyloid polyneuropathy impact on health-related quality of life
por: Inês, Mónica, et al.
Publicado: (2015)

Teachings from the French database of TTR familial amyloidotic polyneuropathy (TTR-FAP): large genetic and phenotypic heterogeneity, usefulness of TTR gene testing.
por: Adams, David, et al.
Publicado: (2015)

Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP
por: Parman, Yesim, et al.
Publicado: (2016)

Familial amyloid polyneuropathy in Portugal: New genes modulating age‐at‐onset
por: Santos, Diana, et al.
Publicado: (2016)

Diflunisal in late-onset FAP patients with moderate to severe neuropathy
por: Obici, Laura, et al.
Publicado: (2015)

Axon reflex-mediated vasodilation is reduced in proportion to disease severity in familial amyloid polyneuropathy
por: Kuntzer, Thierry, et al.
Publicado: (2015)

Life paths of familial amiloidotic polyneuropathy patients: a descriptive study
por: Lopes, Alice, et al.
Publicado: (2015)

C1QA and C1QC modify age‐at‐onset in familial amyloid polyneuropathy patients
por: Dias, Andreia, et al.
Publicado: (2019)

Familial Adenomatous Polyposis (FAP) in 9 Hispanic women
por: Ricker, Charite, et al.
Publicado: (2010)

Epidemiology of Familial Amyloid Polyneuropathy in Bulgaria
por: Sarafov, Stayko, et al.
Publicado: (2015)

Positive real-world effectiveness of tafamidis for delaying disease progression in transthyretin familial amyloid polyneuropathy
por: Stewart, Michelle, et al.
Publicado: (2015)

Phase 2 open-label extention (OLE) study of patisiran, an investigational siRNA agent for familial amyloidotic polyneuropathy (FAP)
por: Adams, David, et al.
Publicado: (2015)

Clinical and laboratory test in patients with familial amyloid polyneuropathy: differences between symptomatic patients and asymptomatic carriers
por: Raya-Cruz, Manuel, et al.
Publicado: (2015)

Familial Amyloid Polyneuropathy treatment with Tafamidis – evaluation of one- and two-year treatment in Porto, Portugal
por: Coelho, Teresa, et al.
Publicado: (2015)

A Familial Adenomatous Polyposis (FAP) patient education conference and its impact on patients and families
por: Saraiya, Devki S, et al.
Publicado: (2010)

Early intervention with tafamidis provides long-term benefit in delaying neurological progression in patients with transthyretin familial amyloid polyneuropathy
por: Waddington-Cruz, Marcia, et al.
Publicado: (2015)

Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
por: Rousseau, Antoine, et al.
Publicado: (2015)

The diagnostic accuracy of Sudoscan in TTR-FAP
por: Castro, Jose, et al.
Publicado: (2015)

Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area
por: Mazzeo, Anna, et al.
Publicado: (2015)

Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial
por: Keohane, Denis, et al.
Publicado: (2015)

Vasculopathy in transthyretin Val30Met familial amyloid polyneuropathy
por: Koike, Haruki, et al.
Publicado: (2015)

Retinal and choroidal vascular abnormalities in TTR-FAP
por: Rousseau, Antoine, et al.
Publicado: (2015)

Tissue remodeling after RNAi-mediated knockdown of TTR in a Familial Amyloidotic Polyneuropathy mouse model
por: Gonçalves, Nádia Pereira, et al.
Publicado: (2015)

Neurophysiological pitfalls in TTR-FAP Val30Met
por: Conceição, Isabel, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ei8iqqftss86t85v9g80atsbro